Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Stricture Definition and Treatment (STRIDENT) Drug Therapy Study

Trial Profile

Stricture Definition and Treatment (STRIDENT) Drug Therapy Study

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Jan 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Adalimumab (Primary) ; Purines
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Acronyms STRIDENT
  • Most Recent Events

    • 04 Dec 2019 Status changed from recruiting to active, no longer recruiting.
    • 29 Aug 2019 Planned End Date changed from 1 Sep 2019 to 1 Sep 2020.
    • 29 Aug 2019 Planned primary completion date changed from 1 Jul 2019 to 1 Sep 2020.
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top